tiprankstipranks
Trending News
More News >
Palatin Technologies, Inc. (PTNT)
:PTNT
US Market
Advertisement

Palatin Technologies (PTNT) Price & Analysis

Compare
Followers

PTNT Stock Chart & Stats


PTNT FAQ

What was Palatin Technologies, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Palatin Technologies, Inc.’s market cap?
Currently, no data Available
When is Palatin Technologies, Inc.’s upcoming earnings report date?
Palatin Technologies, Inc.’s upcoming earnings report date is Oct 07, 2025 which is in 35 days.
    How were Palatin Technologies, Inc.’s earnings last quarter?
    Palatin Technologies, Inc. released its earnings results on May 14, 2025. The company reported -$9 earnings per share for the quarter, missing the consensus estimate of -$8.5 by -$0.5.
      Is Palatin Technologies, Inc. overvalued?
      According to Wall Street analysts Palatin Technologies, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Palatin Technologies, Inc. pay dividends?
        Palatin Technologies, Inc. does not currently pay dividends.
        What is Palatin Technologies, Inc.’s EPS estimate?
        Palatin Technologies, Inc.’s EPS estimate is -9.5.
          How many shares outstanding does Palatin Technologies, Inc. have?
          Currently, no data Available
          What happened to Palatin Technologies, Inc.’s price movement after its last earnings report?
          Palatin Technologies, Inc. reported an EPS of -$9 in its last earnings report, missing expectations of -$8.5. Following the earnings report the stock price went up 14.88%.
            Which hedge fund is a major shareholder of Palatin Technologies, Inc.?
            Currently, no hedge funds are holding shares in PTNT

            Palatin Technologies (PTNT) Earnings & Revenues

            PTNT Earnings Call

            Q3 2025
            0:00 / 0:00
            Earnings Call Sentiment|Neutral
            The earnings call presented a mixed view with significant achievements in reducing net loss and promising clinical trial results. However, challenges remain with the absence of product sales and a decrease in cash position. The company is actively pursuing strategic partnerships to enhance its future prospects.View all PTNT earnings summaries
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis